Crossmark

A single-arm phase II study of nab-paclitaxel for patients with chemorefractory non-small cell lung cancer

Crossref DOI link: https://doi.org/10.1186/s12885-017-3684-8

Published Online: 2017-10-16

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tanaka, Hisashi

Taima, Kageaki

Morimoto, Takeshi

Tanaka, Yoshihito

Itoga, Masamichi

Nakamura, Kunihiko

Hayashi, Akihito

Kumagai, Mika

Yasugahira, Hideo

Mikuniya, Megumi

Okudera, Koichi

Takanashi, Shingo

Tasaka, Sadatomo